Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Breast Neoplasms 60Prostatic Neoplasms 52Squamous Cell Carcinoma of Head and Neck 43Carcinoma, Non-Small-Cell Lung 39Head and Neck Neoplasms 37Lung Neoplasms 35Lymphoma 34Leukemia 22Brain Neoplasms 20Central Nervous System Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Rectal Neoplasms 17Lymphoma, Follicular 16Esophageal Squamous Cell Carcinoma 16Esophageal Neoplasms 15Lymphoma, Large B-Cell, Diffuse 14Hodgkin Disease 14Burkitt Lymphoma 14Adenocarcinoma of Lung 13Oligodendroglioma 12Lymphoma, Non-Hodgkin 12Neoplasm Metastasis 11Astrocytoma 11Rhabdomyosarcoma 10Lymphoma, Large-Cell, Immunoblastic 10Neuroblastoma 9Nasopharyngeal Carcinoma 9

Interventions

Radiotherapy 2Temozolomide 1Nimorazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Hypoxia × Radiotherapy × Clear all
NCT06477939 2024-06-27

THREE-GLEES

Institut de cancérologie Strasbourg Europe

Phase 3 Not yet recruiting
554 enrolled
CNS

Hypoxia, Brain Neoplasms, Glioblastoma

NCT01212354 2016-02-09

Escalox

Technical University of Munich

Phase 3 Unknown
270 enrolled
Head & Neck

Hypoxia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡